MaxCyte, Inc. (NASDAQ: MXCT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MAXCYTE, INC.

MaxCyte, Inc. (NASDAQ: MXCT)
Listen to this Section


$1.19
-0.0400 ( -3.25% ) 191.3K

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Market Data


Open $1.19
Previous Close $1.23
Volume 191.3K
Market Cap $128.55M
Day Range $1.18 - $1.25
52 Week Range $0.64 - $2.40
Shares Outstanding 107.12M
Change % -3.25%
Net Change ▼ -0.0400
Insider Ownership -0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -362,372.00

Date Type Amount Purchased Purchaser
2023-11-29 Sale -5000.00 Johnston John Joseph
2023-11-16 Sale -8717.00 Johnston John Joseph
2023-08-30 Sale -100.00 Johnston John Joseph

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 74 Nov 13, 2025
8-k 8K-related 42 Nov 12, 2025
8-k 8K-related 14 Nov 05, 2025
8-k 8K-related 14 Sep 22, 2025
4 Insider transactions 1 Aug 27, 2025
4 Insider transactions 1 Aug 13, 2025
4 Insider transactions 1 Aug 13, 2025
4 Insider transactions 1 Aug 13, 2025
4 Insider transactions 1 Aug 13, 2025
4 Insider transactions 1 Aug 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy